Virtual, Interactive Conference!

Friday, October 2, 2020 - 8:00 AM - 5:20 PM CDT
Saturday, October 3, 2020 - 8:30 AM - 4:20 PM CDT

Physicians’ Education Resource^®, LLC (PER^®), is pleased to present the 2020 Gastrointestinal Oncology Conference, the 17th annual meeting of the International Society of Gastrointestinal Oncology (ISGIO), a 2-day, multidisciplinary educational conference dedicated to presenting and discussing the latest advances in the broad field of gastrointestinal (GI) cancer research, as well as critical issues relevant to the care of persons with GI cancer.

GI malignancies are often difficult to treat because of their heterogeneity, and the optimal management of these tumors often requires a high level of multidisciplinary cooperation and multimodality treatment regimens.

This highly engaging conference brings together world-renowned experts from different disciplines to educate clinicians using a combination of case-based learning, debates, panel discussions, and didactic segments. Throughout the educational sessions, attendees will have numerous opportunities to interact with the presenting faculty.

• Network with your peers and world-renowned thought leaders
• Learn the latest about new and emerging treatment options for a variety of GI malignancies
• Hear expert perspectives on areas of clinical uncertainty and controversy
• Improve the patient-centered care you provide to your patients

This activity is supported by educational grants from Advanced Accelerator Applications USA, Inc.; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo, Inc.; Exelixis, Inc.; Ipsen Biopharmaceuticals, Inc.; Lilly; Pfizer Inc.; Sumitomo Dainippon Pharma Oncology, Inc.; and Taiho Oncology, Inc.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

This educational activity is directed toward oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in GI oncology. Other health care professionals interested in the treatment of these malignancies are also invited to participate.

At the conclusion of this activity, participants should be better prepared to:

• Describe current standards of care for treatment of gastrointestinal (GI) malignancies
• Discuss recent advances and innovations in the management of GI malignancies
• Analyze clinical trial data that may impact treatment decision making in GI oncology
• Implement a multimodal approach to the treatment of GI malignancies, including gastric, pancreatic, and colorectal cancers, hepatocellular carcinoma, and cholangiocarcinoma

• The expanding role of immunotherapy in the treatment of GI malignancies
• New/Novel targets and targeted therapies
• Advances in the multidisciplinary approach to the management of GI malignancies